- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: ORGN001 (formerly ALXN1101)
Total 221 results
-
Origin BiosciencesCompletedMolybdenum Cofactor Deficiency, Type AUnited States, Australia, Netherlands, United Kingdom, Tunisia
-
Origin BiosciencesCompletedMolybdenum Cofactor Deficiency, Type AUnited States, Spain, Israel, Norway, Turkey, United Kingdom
-
Alexion PharmaceuticalsTerminatedParoxysmal Nocturnal Hemoglobinuria (PNH)United States, Czech Republic, Italy, Poland, United Kingdom
-
Origin BiosciencesCompletedMolybdenum Cofactor Deficiency (MoCD) | Rare Autosomal Recessive Disorder | Deficiency of Activity of Molybdenum-dependent Enzymes (Sulfite Oxidase [SOX], Xanthine Dehydrogenase, and Aldehyde Oxidase)United States
-
IWK Health CentreMcGill University; Canadian Institutes of Health Research (CIHR); University... and other collaboratorsActive, not recruiting
-
GlaxoSmithKlineCompletedCarcinoma, Renal CellUnited States
-
GlaxoSmithKlineCompleted
-
IWK Health CentreCanadian Institutes of Health Research (CIHR)CompletedAnxiety DisorderCanada
-
Reneo Pharma LtdTerminatedPrimary Mitochondrial MyopathySpain, Australia, Belgium, Denmark, Canada, United Kingdom, France, Germany, Hungary, Italy, Netherlands, New Zealand
-
Digital Diagnostics, Inc.The Emmes Company, LLCCompleted
-
Cinclus Pharma AGCompletedPharmacokinetics | Bioavailability | SafetySlovenia
-
BrainQ Technologies Ltd.Terminated
-
Leap Therapeutics, Inc.CompletedMultiple Myeloma | Non-Small Cell Lung Cancer | Solid TumorsUnited States
-
NOCwatch InternationalNational Institutes of Health (NIH); National Institute on Aging (NIA)CompletedInjuries | Fractures | Accidental FallsUnited States
-
IWK Health CentreCanadian Institutes of Health Research (CIHR)CompletedOppositional Defiant Disorder | Behaviour DisorderCanada
-
Alexion Pharmaceuticals, Inc.Active, not recruitingGeneralized Myasthenia Gravis | Myasthenia GravisUnited States, Spain, Korea, Republic of, Canada, Germany, Italy, Serbia, Taiwan
-
Columbia UniversityTG Therapeutics, Inc.Terminated
-
Orinove, Inc.Fosun PharmaActive, not recruiting
-
Reneo Pharma LtdCompletedFatty Acid Oxidation DisordersUnited States, France, Spain
-
Ore Pharmaceuticals, Inc.UnknownMild to Moderate Ulcerative ColitisCanada, India
-
Reciprocal LabsCalifornia HealthCare FoundationCompleted
-
AlexionRecruitingHealthy | Impaired Hepatic FunctionUnited States
-
New York State Psychiatric InstituteCompletedObsessive-Compulsive Disorder (OCD)United States
-
Orinove, Inc.Vanderbilt UniversityActive, not recruitingIdiopathic Pulmonary FibrosisUnited States
-
Alexion PharmaceuticalsCompleted
-
Hadassah Medical OrganizationNexcella, IncRecruiting
-
AlexionCompleted
-
Upstream Bio Inc.Completed
-
AmgenCompletedMyelodysplastic Syndromes | Thrombocytopenia | MDS | Hematology
-
IWK Health CentreCanadian Institutes of Health Research (CIHR)CompletedPediatric Disruptive Behaviour DisorderCanada
-
AlexionCompleted
-
AlexionCompletedHealthyUnited States
-
Columbia UniversityTerminatedHodgkin Disease | Lymphoma, Non-hodgkinUnited States
-
Kibow PharmaRecruitingChronic Kidney Disease stage4United States
-
Alexion PharmaceuticalsCompleted
-
University of PennsylvaniaWeight Watchers InternationalCompleted
-
ShireCompleted
-
ClearLine MDCompletedAir Leakage | Air Embolism | Air Burden
-
vTv TherapeuticsCompletedType 2 Diabetes MellitusUnited States
-
Thallion PharmaceuticalsTerminatedMelanomaUnited States, Canada
-
Thallion PharmaceuticalsTerminatedGlioblastoma MultiformeUnited States, Canada
-
PfizerActive, not recruitingHemophilia BUnited States, Canada, Australia, Turkey
-
Reneo Pharma LtdCompletedMcArdle DiseaseSpain, United Kingdom
-
Reneo Pharma LtdTerminatedPrimary Mitochondrial MyopathyUnited Kingdom
-
AstraZenecaCompleted
-
Alexion PharmaceuticalsCompleted
-
Alexion PharmaceuticalsTerminatedAcute Graft-Versus-Host Disease | GIGVHDUnited States, France
-
Alexion PharmaceuticalsTerminatedAntiphospholipid (aPL)-PositiveUnited States, Italy, Brazil, France, Japan, United Kingdom
-
Alexion PharmaceuticalsCompleted
-
Navire Pharma Inc., a BridgeBio companyActive, not recruitingTumor, SolidUnited States